Getting latest data loading
Home / Morning Report / Morning Report

This report is not a personal recommendation and does not take into account your personal circumstances or appetite for risk.

Morning Report - 21 December 2021

Yesterday’s UK 100 Leaders Price (p) % Chg
RENTOKIL INITIAL PLC 569.8 6.5%
DECHRA PHARMACEUTICALS PLC 5,090.0 1.7%
ROYAL MAIL PLC 503.6 1.5%
SAGE GROUP PLC/THE 823.2 1.2%
TESCO PLC 287.6 1.1%
Yesterday’s UK 100 Laggards Price (p) % Chg
ANTOFAGASTA PLC 1294.0 -5.5%
INFORMA PLC 475.4 -5.3%
PRUDENTIAL PLC 1217.0 -4.6%
ABRDN PLC 226.6 -4.4%
DS SMITH PLC 372.2 -3.5%
Major World Indices Price % Chg 1 YEAR
UK 100 INDEX 7,198 -1.0% 10.2%
DOW JONES INDUS. AVG 34,932 -1.2% 15.8%
DAX INDEX 15,240 -1.9% 11.8%
NIKKEI 225 27,938 -2.1% 4.6%
S&P/ASX 200 INDEX 7,292 -0.2% 9.3%
Commodities Units Price % Chg
WTI Crude Oil (Nymex) USD/bbl. 68.23 -3.71%
Brent Crude (ICE) USD/bbl. 72.15 -1.86%
Gold Spot USD/t oz. 1,791 0.0%
Copper (Comex) USd/lb. 429 0.0%

 

The UK 100 is called to open +100 points today at 7290.

4 hours; 10 Months

Click graph to enlarge

Markets Overview:

 

 

The UK 100 is called to open +100 points today at 7290.  The UK’s blue chip index looks set to bounce back strongly after yesterday’s Omicron-inspired sell-off.  Shares in Asia rose this morning thanks to a wave of short-covering lifting stocks as investors remained concerned about Omicron risks.  The Nikkei in Japan led gains regionally, surging 2.08% while South Korea’s Kospi rose 0.41%.  China’s Shanghai Composite lifted 0.81% and Hong Kong’s Hang Seng gained 0.86%.  It was a more difficult session on Wall Street yesterday, The Dow Jones dropped 433.28 points to 34,932.16, dragged down by losses in Boeing, Goldman Sachs and American Express. The S&P 500 dipped 1.1% to 4,568.02 and the technology-focused Nasdaq Composite declined 1.2% to 14,980.94. The small-cap benchmark Russell 2000 lost nearly 1.6%.

 

Company News & Broker Comments:

 

 

Company News:

AstraZeneca treatment Ultomiris accepted for priority review by US FDA.
 
Foxtons promotes director of Finance Chris Hough to CFO to replace departing Harris.
GlaxoSmithKline: The US Food 7 Drug Administration approved an injectable form of GSK's cabotegravir drug that is given every two months to prevent an HIV infection.
Hiscox names Prudential Assurance CFO Paul Cooper as CFO.
Schroders agrees deal to acquire majority stake in Greencoat Capital for £358m.

 

Broker Comments

No new broker comments

 

 

Reporting Today:

 

 

None

 

 

Reporting Tomorrow:

 

 

None

 

 

In Focus Today:

 

 

BoJ Monetary Policy Meeting Minutes

German Gfk Consumer Confidence Survey

EU Consumer Confidence

 

 

This Week's Ex-Dividends:

 

FTSE 100:

 

Evraz

British American Tobacco

Halma

 

FTSE 250:

 

IntegraFin Holdings

Mercantile Investment Trust

 

For any help you may require placing trades or in terms of market information, put a call in to our trading floor – it’s all part of the service.


Back to Top

This research is produced by Accendo Markets Limited. Research produced and disseminated by Accendo Markets is classified as non-independent research, and is therefore a marketing communication. This investment research has not been prepared in accordance with legal requirements designed to promote its independence and it is not subject to the prohibition on dealing ahead of the dissemination of investment research. This research does not constitute a personal recommendation or offer to enter into a transaction or an investment, and is produced and distributed for information purposes only.


Accendo Markets considers opinions and information contained within the research to be valid when published, and gives no warranty as to the investments referred to in this material. The income from the investments referred to may go down as well as up, and investors may realise losses on investments. The past performance of a particular investment is not necessarily a guide to its future performance.

Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage.
Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 69% of retail investor accounts lose money when spread betting and/or trading CFDs with this provider. You should consider whether you understand how spread bets and CFDs work and whether you can afford to take the high risk of losing your money.
.